Repligen Corp (RGEN)
167.86
-3.42
(-2.00%)
USD |
NASDAQ |
Apr 24, 16:00
167.51
-0.35
(-0.21%)
After-Hours: 20:00
Repligen Cash from Financing (TTM): 248.96M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 248.96M |
| September 30, 2023 | -19.44M |
| June 30, 2023 | -17.41M |
| March 31, 2023 | -10.88M |
| December 31, 2022 | -13.34M |
| September 30, 2022 | -12.83M |
| June 30, 2022 | -14.20M |
| March 31, 2022 | -11.57M |
| December 31, 2021 | 0.961M |
| September 30, 2021 | 299.57M |
| June 30, 2021 | 301.37M |
| March 31, 2021 | 304.83M |
| December 31, 2020 | 305.92M |
| September 30, 2020 | 6.898M |
| June 30, 2020 | 300.10M |
| March 31, 2020 | 486.41M |
| December 31, 2019 | 484.87M |
| September 30, 2019 | 486.09M |
| June 30, 2019 | 192.10M |
| March 31, 2019 | 3.118M |
| December 31, 2018 | 3.407M |
| September 30, 2018 | 2.666M |
| June 30, 2018 | 131.60M |
| March 31, 2018 | 130.61M |
| December 31, 2017 | 129.94M |
| Date | Value |
|---|---|
| September 30, 2017 | 129.55M |
| June 30, 2017 | 0.158M |
| March 31, 2017 | 111.46M |
| December 31, 2016 | 112.11M |
| September 30, 2016 | 112.14M |
| June 30, 2016 | 111.96M |
| March 31, 2016 | 0.787M |
| December 31, 2015 | 0.767M |
| September 30, 2015 | 1.626M |
| June 30, 2015 | 0.9291M |
| March 31, 2015 | 1.485M |
| December 31, 2014 | 1.68M |
| September 30, 2014 | 1.545M |
| June 30, 2014 | 1.825M |
| March 31, 2014 | 2.063M |
| December 31, 2013 | 2.522M |
| September 30, 2013 | 2.132M |
| June 30, 2013 | 3.059M |
| March 31, 2013 | 2.002M |
| December 31, 2012 | 1.159M |
| September 30, 2012 | 0.5559M |
| June 30, 2012 | -0.1959M |
| March 31, 2012 | -0.2365M |
| September 30, 2011 | -0.4069M |
| June 30, 2011 | -0.067M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-19.44M
Minimum
Sep 2023
486.41M
Maximum
Mar 2020
174.65M
Average
192.10M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
| Perspective Therapeutics Inc | 0.785M |
| Retractable Technologies Inc | 0.9416M |
| Xtant Medical Holdings Inc | 19.69M |
| Asensus Surgical Inc | 9.626M |
| Catheter Precision Inc | 8.386M |